Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sikarin PCLBKK:SKR-R -0.63%90 Pretax Margin % is 13.94% as of Jun. 2026, which is 15% above its 10-year median of 12.08. GuruFocus rates BKK:SKR-R with a GF Score™ of 90/100 and a GF Value™ of ฿8.11 (Fairly Valued). The stock has 5 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Sikarin PCL ranks better than 78.77% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Sikarin PCL's Pre-Tax Income for the
three
months ended in Jun. 2026 was ฿191 Mil. Sikarin PCL's Revenue for the
three
months ended in Jun. 2026 was ฿1,367 Mil. Therefore, Sikarin PCL's pretax margin for the quarter that ended in Jun. 2026 was 13.94%.
The historical rank and industry rank for Sikarin PCL's Pretax Margin % or its related term are showing as below:
BKK:SKR-R'
s Pretax Margin % Range Over the Past 10 Years
Min: 6.48 Med: 12.08 Max: 27.83
Current: 13.46
BKK:SKR-R's Pretax Margin % is ranked better than 78.77% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 4.09
vs BKK:SKR-R: 13.46
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Sikarin PCL Pretax Margin % Related Terms
Sikarin PCL Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Sikarin PCL's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SKR-R vs HCA, THC, DVA: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, Sikarin PCL's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sikarin PCL Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sikarin PCL's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Sikarin PCL's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sikarin PCL (BKK:SKR-R) has a Pretax Margin % of 13.94% as of Jun. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sikarin PCL and its competitors. This is 15% above median its historical median of 12.08. Over the past decade, Sikarin PCL's Pretax Margin % has ranged from 6.48 to 27.83. According to the industry distribution chart, Sikarin PCL ranks #142 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 21.2%.
Is Sikarin PCL's Pretax Margin % too high?
Sikarin PCL's current Pretax Margin % of 13.94% is 15% above median its 10-year median of 12.08. Over the past 10 years, this metric has ranged from a low of 6.48 to a high of 27.83. The Healthcare Providers & Services industry median Pretax Margin % is 4.09. Sikarin PCL's value of 13.94% is 240.8% above this industry median. Based on the distribution chart, Sikarin PCL ranks #142 out of 669 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sikarin PCL has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sikarin PCL's Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sikarin PCL ranks #142 out of 669 companies for Pretax Margin %. This places Sikarin PCL in the top 21% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 4.09. Sikarin PCL's value of 13.94% is 240.8% above this benchmark. Historically, Sikarin PCL's own Pretax Margin % has ranged from 6.48 to 27.83 over the past decade. While the company's 10-year median is 12.08 vs. the industry median of 4.09, Sikarin PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.09, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sikarin PCL's current Pretax Margin % of 13.94% is 240.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sikarin PCL and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sikarin PCL's current Pretax Margin % is 13.94%, which is 15% above median its own 10-year median of 12.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sikarin PCL stock overvalued right now?
Based on GuruFocus' analysis, Sikarin PCL (BKK:SKR-R) is currently considered Fairly Valued. The stock's GF Value™ is ฿8.11, compared to a current price of ฿7.85 — trading 3.2% below its estimated fair value. The current Pretax Margin % is 13.94%, which is 15% above median its 10-year median of 12.08 and 240.8% above the Healthcare Providers & Services industry median of 4.09. Sikarin PCL's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Sikarin PCL (BKK:SKR-R), the current Pretax Margin % is 13.94% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sikarin PCL (BKK:SKR-R) Overvalued in 2026?
Based on GuruFocus' analysis, Sikarin PCL stock appears to be undervalued.
The current stock price of ฿7.85 is trading 3.2% below its estimated GF Value™ of ฿8.11.
GuruFocus considers Sikarin PCL to be Fairly Valued.
Key valuation signals for BKK:SKR-R:
Pretax Margin %: 13.94% (15% above median its 10-year median of 12.08)
GF Value™: ฿8.11 vs. price of ฿7.85 (3.2% below fair value)
Industry Position: 240.8% above the Healthcare Providers & Services median (#142 of 669)
No single metric tells the full story. See the BKK:SKR-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSikarin PCL provides general healthcare services and operates under the social security system. The Group has one main operating segment, which is providing healthcare services through private hospitals and hospitals affiliated with the social security system. The Group operates in a single geographical area, which is Thailand. Its services include medical centers, a pediatric center, a women's institute, a radiology center, a neurology center, a rehabilitation center, and an orthopedic center.
90GF Score
Get the complete analysis for BKK:SKR-R
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SKR-R has been successfully added to your 
